Remdesivir approved as COVID-19 treatment in Canada, but it’s in short supply

Health Canada has approved remdesivir as the country’s first COVID-19 treatment, but there are concerns about the drug’s availability after the U.S. bought up most of the manufacturer’s supply.

Watch The National live on YouTube Sunday-Friday at 9 p.m. ET

Subscribe to The National:

Connect with The National online:
Facebook |
Twitter |
Instagram |

More from CBC News |

The National is CBC’s flagship nightly news program, featuring the day’s top stories with in-depth and original journalism, with hosts Adrienne Arsenault and Andrew Chang in Toronto, Ian Hanomansing in Vancouver and the CBC’s chief political correspondent, Rosemary Barton in Ottawa.

Leave a Comment